Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – Should You Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKYGet Free Report) shares saw unusually-high trading volume on Thursday . Approximately 40,822 shares traded hands during trading, an increase of 61% from the previous session’s volume of 25,427 shares.The stock last traded at $12.0590 and had previously closed at $11.91.

Analyst Ratings Changes

Separately, UBS Group upgraded shares of Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, Nihon Kohden presently has a consensus rating of “Strong Buy”.

View Our Latest Report on NHNKY

Nihon Kohden Price Performance

The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 22.65 and a beta of 0.37. The stock has a fifty day moving average of $11.16 and a 200 day moving average of $11.37.

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.16 EPS for the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%.The business had revenue of $362.86 million during the quarter.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.